WO2001005974A3 - The il-1l1 gene and polypeptide products - Google Patents
The il-1l1 gene and polypeptide products Download PDFInfo
- Publication number
- WO2001005974A3 WO2001005974A3 PCT/US2000/019508 US0019508W WO0105974A3 WO 2001005974 A3 WO2001005974 A3 WO 2001005974A3 US 0019508 W US0019508 W US 0019508W WO 0105974 A3 WO0105974 A3 WO 0105974A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- polypeptide products
- polypeptide
- 1beta
- interleukin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002378954A CA2378954A1 (en) | 1999-07-16 | 2000-07-17 | The il-1l1 gene and polypeptide products |
JP2001511187A JP2003523943A (en) | 1999-07-16 | 2000-07-17 | IL-1L1 gene and polypeptide products |
EP00948733A EP1200593A2 (en) | 1999-07-16 | 2000-07-17 | The il-1l1 gene and polypeptide products |
AU62194/00A AU6219400A (en) | 1999-07-16 | 2000-07-17 | The il-1l1 gene and polypeptide products |
IL14753400A IL147534A0 (en) | 1999-07-16 | 2000-07-17 | The il-il1 gene and polypeptide products |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14429899P | 1999-07-16 | 1999-07-16 | |
US60/144,298 | 1999-07-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001005974A2 WO2001005974A2 (en) | 2001-01-25 |
WO2001005974A3 true WO2001005974A3 (en) | 2001-05-10 |
WO2001005974A9 WO2001005974A9 (en) | 2001-06-28 |
Family
ID=22507973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/019508 WO2001005974A2 (en) | 1999-07-16 | 2000-07-17 | The il-1l1 gene and polypeptide products |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1200593A2 (en) |
JP (1) | JP2003523943A (en) |
AU (1) | AU6219400A (en) |
CA (1) | CA2378954A1 (en) |
IL (1) | IL147534A0 (en) |
WO (1) | WO2001005974A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2317918A1 (en) | 1998-01-09 | 1999-07-15 | Immunex Corporation | Il-1 delta dna and polypeptides |
EP1407005A4 (en) * | 2001-06-11 | 2006-05-31 | Interleukin Genetics Inc | Integrative assays for monitoring molecular assembly events |
EP2500438A3 (en) * | 2002-09-25 | 2012-11-28 | Genentech, Inc. | Novel compositions and methods for the treatment of psoriasis |
US20100031378A1 (en) | 2008-08-04 | 2010-02-04 | Edwards Joel A | Novel gene disruptions, compositions and methods relating thereto |
WO2005085866A1 (en) * | 2004-02-27 | 2005-09-15 | Novartis Ag | Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors |
CA2662549C (en) * | 2006-09-08 | 2014-10-28 | Amgen Inc. | Il-1 family variants |
EP3554343A1 (en) * | 2016-12-14 | 2019-10-23 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an il-1 inhibitor |
CN107362351B (en) * | 2017-09-04 | 2020-11-10 | 上海市儿童医院 | Application of IL-36R antagonist in preparation of analgesic drugs |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998047921A1 (en) * | 1997-04-21 | 1998-10-29 | Schering Corporation | Mammalian cytokines; related reagents and methods |
WO1999035268A1 (en) * | 1998-01-09 | 1999-07-15 | Immunex Corporation | IL-1 delta DNA AND POLYPEPTIDES |
WO1999051744A2 (en) * | 1998-04-03 | 1999-10-14 | Hyseq, Inc. | A interleukin-1 receptor antagonist and uses thereof |
WO2000008045A2 (en) * | 1998-08-07 | 2000-02-17 | Millennium Pharmaceuticals, Inc. | Novel molecules of the tango-93-related protein family and uses thereof |
WO2000020595A1 (en) * | 1998-10-08 | 2000-04-13 | Zymogenetics, Inc. | Interleukin-1 homolog |
WO2000039297A2 (en) * | 1998-12-23 | 2000-07-06 | Genentech, Inc. | Il-1 related polypeptides |
-
2000
- 2000-07-17 WO PCT/US2000/019508 patent/WO2001005974A2/en not_active Application Discontinuation
- 2000-07-17 AU AU62194/00A patent/AU6219400A/en not_active Abandoned
- 2000-07-17 EP EP00948733A patent/EP1200593A2/en not_active Withdrawn
- 2000-07-17 JP JP2001511187A patent/JP2003523943A/en not_active Abandoned
- 2000-07-17 IL IL14753400A patent/IL147534A0/en unknown
- 2000-07-17 CA CA002378954A patent/CA2378954A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998047921A1 (en) * | 1997-04-21 | 1998-10-29 | Schering Corporation | Mammalian cytokines; related reagents and methods |
WO1999035268A1 (en) * | 1998-01-09 | 1999-07-15 | Immunex Corporation | IL-1 delta DNA AND POLYPEPTIDES |
WO1999051744A2 (en) * | 1998-04-03 | 1999-10-14 | Hyseq, Inc. | A interleukin-1 receptor antagonist and uses thereof |
WO2000008045A2 (en) * | 1998-08-07 | 2000-02-17 | Millennium Pharmaceuticals, Inc. | Novel molecules of the tango-93-related protein family and uses thereof |
WO2000020595A1 (en) * | 1998-10-08 | 2000-04-13 | Zymogenetics, Inc. | Interleukin-1 homolog |
WO2000039297A2 (en) * | 1998-12-23 | 2000-07-06 | Genentech, Inc. | Il-1 related polypeptides |
Also Published As
Publication number | Publication date |
---|---|
AU6219400A (en) | 2001-02-05 |
WO2001005974A2 (en) | 2001-01-25 |
JP2003523943A (en) | 2003-08-12 |
EP1200593A2 (en) | 2002-05-02 |
IL147534A0 (en) | 2002-08-14 |
CA2378954A1 (en) | 2001-01-25 |
WO2001005974A9 (en) | 2001-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001036473A3 (en) | Human g protein-coupled receptors | |
WO2003004622A3 (en) | Human secreted proteins | |
CA2200423A1 (en) | Novel estrogen receptor | |
CA2285040A1 (en) | Death domain containing receptor 5 | |
WO2004039951A3 (en) | Il-1 receptor based antagonists and methods of making and using | |
WO2002002636A3 (en) | Membrane associated protein zupari | |
WO2001048015A3 (en) | G protein-coupled receptors | |
WO2003004623A3 (en) | Human secreted proteins | |
EP1003767A4 (en) | Human tumor necrosis factor receptor tr10 | |
WO2001005974A3 (en) | The il-1l1 gene and polypeptide products | |
AU5282600A (en) | Interleukin-1 hy2 materials and methods | |
WO2000066156A8 (en) | Death domain containing receptor 5 | |
WO2002086156A3 (en) | New polynucleotides and polypeptides of the ifn$g(a)-17 gene | |
WO2002081517A3 (en) | Novel polypeptides and nucleic acids encoded thereby | |
WO2000054651A3 (en) | Human tumor necrosis factor receptor-like genes | |
WO2001085792A8 (en) | Mu-1, member of the cytokine receptor family | |
WO2002070565A3 (en) | High-affinity antagonists of elr-cxc chemokines | |
WO2001066750A3 (en) | G protein-coupled receptors | |
WO2004042000A3 (en) | 157 human secreted proteins | |
WO2001066598A3 (en) | Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods | |
WO2002085922A3 (en) | Proteins and nucleic acids encoding same | |
WO2000024771A3 (en) | Nucleic acids encoding osteoprotegerin-like proteins and methods of using same | |
WO2002101048A3 (en) | NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE | |
WO2001068674A3 (en) | Preparation of recombinant proteins containing repeating units | |
AU2002333654A1 (en) | Mcfp encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/19-19/19, DRAWINGS, REPLACED BY NEW PAGES 1/19-19/19; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 147534 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2378954 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 62194/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000948733 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000948733 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000948733 Country of ref document: EP |